Shouming Wang
Department of Medicinal Chemistry
Xenova Ltd.
957 Buckingham Avenue
Slough
UK
Name/email consistency: high
- Structure-activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576. Wang, S., Miller, W., Milton, J., Vicker, N., Stewart, A., Charlton, P., Mistry, P., Hardick, D., Denny, W.A. Bioorg. Med. Chem. Lett. (2002)
- Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance. Wang, S., Ryder, H., Pretswell, I., Depledge, P., Milton, J., Hancox, T.C., Dale, I., Dangerfield, W., Charlton, P., Faint, R., Dodd, R., Hassan, S. Bioorg. Med. Chem. Lett. (2002)
- Novel inhibitors of plasminogen activator inhibitor-1: development of new templates from diketopiperazines. Wang, S., Golec, J., Miller, W., Milutinovic, S., Folkes, A., Williams, S., Brooks, T., Hardman, K., Charlton, P., Wren, S., Spencer, J. Bioorg. Med. Chem. Lett. (2002)
